Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 03-1994 | 12-1993 | 09-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 95,341 | 68,943 | 70,626 | 60,801 | 48,708 |
| Marketable Securities | 28,330 | 46,162 | 41,509 | 42,225 | 55,300 |
| Receivables | 66,222 | 65,456 | 63,794 | 58,835 | 54,311 |
| Inventories | 50,664 | 46,443 | 43,691 | 41,783 | 43,992 |
| Other current assets | 14,177 | 11,520 | 9,015 | 12,501 | 11,944 |
| TOTAL | $254,734 | $238,524 | $228,635 | $216,145 | $214,255 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 103,118 | 92,837 |
| Investments And Advances | 0 | 0 | 0 | 8,375 | 0 |
| Other Non-Current Assets | 46,240 | 46,282 | 43,041 | 16,887 | 21,207 |
| TOTAL | $46,240 | $46,282 | $43,041 | $128,380 | $114,044 |
| Total Assets | $396,171 | $369,677 | $351,146 | $323,178 | $309,590 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 30,761 | 0 | 0 | 29,456 | 0 |
| Accounts payable and accrued liabilities | 28,848 | 24,684 | 22,132 | 10,689 | 26,047 |
| Accrued Expenses | 0 | 835 | 13,769 | 16,894 | 0 |
| Other current liabilities | 0 | 2,186 | 0 | 0 | 0 |
| TOTAL | $62,515 | $53,787 | $61,905 | $57,074 | $59,894 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,053 | 7,913 | 6,800 | 10,938 | 16,873 |
| TOTAL | $17,753 | $22,432 | $15,459 | $19,360 | $24,766 |
| Total Liabilities | $80,268 | $76,219 | $77,364 | $76,434 | $84,660 |
| Shareholders' Equity | |||||
| Common Shares | 1,018 | 1,018 | 1,018 | 1,018 | 1,018 |
| Retained earnings | 230,876 | 211,118 | 192,654 | 174,626 | 154,580 |
| Other shareholders' equity | -141 | -203 | -415 | -1,155 | -988 |
| TOTAL | $315,903 | $293,458 | $273,782 | $246,744 | $224,930 |
| Total Liabilities And Equity | $396,171 | $369,677 | $351,146 | $323,178 | $309,590 |